GT Biopharma (GTBP) had the highest return between 2012 and 2012 by a US stock, returning 3,044,698,370%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2012-2012	3,044,698,370%
Cenntro Electric (CENN)	2012-2012	114,285,614.27%
QXO (QXO)	2012-2012	8,064,250%
INVO Fertility (IVF)	2012-2012	1,570,809.63%
Xcel Brands (XELB)	2012-2012	1,249,900%
Anfield Energy (AEC)	2012-2012	1,091,672.15%
Versus Systems Inc. (VS)	2012-2012	163,639.24%
Avita Medical (RCEL)	2012-2012	138,788.89%
Cocrystal Pharma (COCP)	2012-2012	77,900%
Nixxy (NIXX)	2012-2012	64,900%
Cementos Pacasmayo SAA ADR (CPAC)	2012-2012	17,249.33%
Intellinetics (INLX)	2012-2012	8,066.67%
Par Pacific (PARR)	2012-2012	1,900%
Actinium Pharmaceuticals (ATNM)	2012-2012	1,400%
Netcapital (NCPL)	2012-2012	600%
Security National Financial (SNFCA)	2012-2012	487.2%
Coda Octopus (CODA)	2012-2012	470.71%
Sarepta Therapeutics (SRPT)	2012-2012	469.54%
Consumer Portfolio Services (CPSS)	2012-2012	452.86%
Optex Systems Holdings, Inc Common Stock (OPXS)	2012-2012	399.99%
Imunon (IMNN)	2012-2012	376.16%
Hovnanian Enterprises (HOV)	2012-2012	366.67%
BOS Better Online Solutions (BOSC)	2012-2012	355.56%
BioLife Solutions (BLFS)	2012-2012	325%
ACADIA Pharmaceuticals (ACAD)	2012-2012	322.73%